• 回到顶部
  • 4006560232
  • 微信扫码咨询

BFB

 

TFK-1人胆管癌细胞

 

BLUEFBIO Product Sheet

 

细胞名称

TFK-1人胆管癌细胞

img1

货物编码

BFN60808817

产品规格

T25培养x1

1.5ml冻存x2

细胞数量

1x10^6

1x10^6

保存温度

37

-198

运输方式

常温保温运输

干冰运输

安全等级

1

用途限制

仅供科   2

 

培养体系

90%DMEM+10%FBS+1%三抗

培养温度

37

二氧化碳浓度

5%

简介

TFK-1人胆管癌细胞63岁男性供体。该细胞源DSMZ

注释

Doubling time: ~37 hours, at 40th passage (PubMed=8693487); ~40 hours (DSMZ).

Omics: Deep exome analysis.

Misspelling: TFKK-1; PubMed=22490663 supplementary figure 2.

基因突变

/

HLA信息

/

STR信息

Amelogenin        X,Y

CSF1PO        10

D5S818        9,12

D7S820        10 (DSMZ)

10,11 (RCB; TKG)

D13S317        14

D16S539        9

TH01        6

TPOX        8

vWA        14,17

参考文献

PubMed=9290701; DOI=10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D

Jia L.-Q., Osada M., Ishioka C., Gamo M., Ikawa S., Suzuki T., Shimodaira H., Niitani T., Kudo T., Akiyama M., Kimura N., Matsuo M., Mizusawa H., Tanaka N., Koyama H., Namba M., Kanamaru R., Kuroki T.

Screening the p53 status of human cell lines using a yeast functional assay.

Mol. Carcinog. 19:243-253(1997)

 

PubMed=22490663; DOI=10.1016/j.bbrc.2012.03.122

Saiki Y., Yoshino Y., Fujimura H., Manabe T., Kudo Y., Shimada M., Mano N., Nakano T., Lee Y., Shimizu S., Oba S., Fujiwara S., Shimizu H., Chen N., Nezhad Z.K., Jin G., Fukushige S., Sunamura M., Ishida M., Motoi F., Egawa S., Unno M., Horii A.

DCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells.

Biochem. Biophys. Res. Commun. 421:98-104(2012)

 

CLPUB00275

Zach S., Birgin E., Ruckert F.

Primary cholangiocellular carcinoma cell lines.

J. Stem Cell Res. Transplant. 2:1013-1013(2015)

 

PubMed=27231123; DOI=10.1158/2159-8290.CD-15-1442

Saha S.K., Gordan J.D., Kleinstiver B.P., Vu P., Najem M.S., Yeo J.-C., Shi L., Kato Y., Levin R.S., Webber J.T., Damon L.J., Egan R.K., Greninger P., McDermott U., Garnett M.J., Jenkins R.L., Rieger-Christ K.M., Sullivan T.B., Hezel A.F., Liss A.S., Mizukami Y., Goyal L., Ferrone C.R., Zhu A.X., Joung J.K., Shokat K.M., Benes C.H., Bardeesy N.

Isocitrate dehydrogenase mutations confer dasatinib hypersensitivity and SRC dependence in intrahepatic cholangiocarcinoma.

Cancer Discov. 6:727-739(2016)

 

PubMed=31077409; DOI=10.1002/hep.30704

Sittithumcharee G., Suppramote O., Vaeteewoottacharn K., Sirisuksakun C., Jamnongsong S., Laphanuwat P., Suntiparpluacha M., Matha A., Chusorn P., Buraphat P., Kakanaporn C., Charngkaew K., Silsirivanit A., Korphaisarn K., Limsrichamrern S., Tripatara P., Pairojkul C., Wongkham S., Sampattavanich S., Okada S., Jirawatnotai S.

Dependency of cholangiocarcinoma on cyclin D-dependent kinase activity.

Hepatology 70:1614-1630(2019)